Matrix Private Capital Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Matrix Private Capital Group's EW Position: Q1 2025 in Review
Matrix Private Capital Group sold out of Edwards Lifesciences (EW) in Q1 2025, closing a stake of 3,317 shares — an estimated $246K sold.
Matrix Private Capital Group first reported a position in EW in Q4 2019 and held it in 21 quarters. The position peaked at $829K in Q4 2021. 1,206 funds tracked by Wall St. Rank hold EW as of Q1 2025.
- Matrix Private Capital Group reported no remaining Edwards Lifesciences position as of Q1 2025 after selling out during the quarter.
- Matrix Private Capital Group sold 3,317 Edwards Lifesciences shares in Q1 2025, an estimated $246K.
- Matrix Private Capital Group first reported a position in Edwards Lifesciences in Q4 2019 and held it in 21 quarters.
- Matrix Private Capital Group's Edwards Lifesciences position peaked at $829K in Q4 2021.
- 1,206 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2025.
Based on Matrix Private Capital Group's 13F filing for Q1 2025, filed 15 May 2025.